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A large GGGGCC hexanucleotide repeat expansion in the first intron or promoter
region of the C9orf72 gene is the most common genetic cause of familial and
sporadic Amyotrophic lateral sclerosis (ALS), a devastating degenerative disease of
motor neurons, and of Frontotemporal Dementia (FTD), the second most common
form of presenile dementia after Alzheimer’s disease. C9orf72-associated ALS/FTD is
a multifaceted disease both in terms of its clinical presentation and the misregulated
cellular pathways contributing to disease progression. Among the numerous pathways
misregulated in C9orf72-associated ALS/FTD, altered RNA processing has consistently
appeared at the forefront of C9orf72 research. This includes bidirectional transcription of
the repeat sequence, accumulation of repeat RNA into nuclear foci sequestering specific
RNA-binding proteins (RBPs) and translation of RNA repeats into dipeptide repeat
proteins (DPRs) by repeat-associated non-AUG (RAN)-initiated translation. Over the past
few years the true extent of RNA misprocessing in C9orf72-associated ALS/FTD has
begun to emerge and disruptions have been identified in almost all aspects of the life of
an RNA molecule, including release from RNA polymerase II, translation in the cytoplasm
and degradation. Furthermore, several alterations have been identified in the processing
of the C9orf72 RNA itself, in terms of its transcription, splicing and localization. This
review article aims to consolidate our current knowledge on the consequence of the
C9orf72 repeat expansion on RNA processing and draws attention to the mechanisms
by which several aspects of C9orf72 molecular pathology converge to perturb every
stage of RNA metabolism.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal progressive neuromuscular disease resulting from
the degeneration of motor neurons in the brain and spinal cord for which no effective treatments
are currently available. Frontotemporal Dementia (FTD), the second most common form
of dementia after Alzheimer’s disease, is characterized by behavioral and language deficits
and manifests pathologically by neuronal atrophy in the frontal and anterior temporal
lobes in the brain. A hexanucleotide G4C2 repeat expansion in the first intron or promoter
region of the C9orf72 gene on chromosome 9p21 represents the most common familial
cause of ALS and FTD (Dejesus-Hernandez et al., 2011; Renton et al., 2011). C9orf72 repeat
expansions manifest pathologically as proteinaceous inclusions of the RNA/DNA binding
protein TDP-43. C9orf72 repeat expansion as a common genetic cause of ALS of FTD further
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 July 2017 | Volume 11 | Article 195
Barker et al. RNA Misprocessing in C9orf72-Linked Neurodegeneration
emphasizes the extensive clinical, genetic and pathological
overlap between these two conditions, suggesting that both
diseases represent opposite ends of a continuous clinical
spectrum. C9orf72 lies at the heart of this spectrum, with the
risk of developing FTD and ALS concurrently increasing from
7% to 30% in expansion carriers (van der Zee et al., 2013). The
number of repeats in the normal population ranges from 2 to
23. Expansion sizes vary considerably between individual cases
and expansion sizes as high as 3500 repeats have been reported
(Chen et al., 2016), however the lower threshold required
to initiate pathogenesis is poorly defined. A report described
an individual with an intermediate repeat length (30 units)
exhibiting some C9orf72-associated pathological phenotypes
in the absence of clinical manifestations (Gami et al., 2015)
suggesting that 30 repeats may lie on the border between initial
cellular abnormalities and full-blown disease. Expansions of
less than 30 repeats are not typically associated with disease;
however a minority of ALS cases with 20–22 repeats have been
described (Byrne et al., 2014). Furthermore, such intermediate
repeat sizes significantly increase the risk of developing ALS
(Chen et al., 2016) and are associated with decreased C9orf72
promoter activity (Gijselinck et al., 2016).
Differential use of transcription alternative start and
termination sites generates three RNA transcripts from C9orf72
DNA. These encode two protein isoforms consisting of a long
isoform (isoform A) of approximately 54 kDa derived from
variants 2 (NM_018325.4) and 3 (NM_001256054.2), and a
short isoform (isoform B) of approximately 24 kDa derived
from variant 1 (NM_145005.6; Figure 1). Several studies have
shown a reduction in C9orf72 mRNA (Dejesus-Hernandez et al.,
2011; Renton et al., 2011; Gijselinck et al., 2012) and protein
levels (Waite et al., 2014) in expansion carriers, suggesting that
toxicity may be mediated by loss of function of the C9orf72-
encoded protein. However, neural-specific ablation of C9orf72
or knockdown using antisense oligonucleotides (ASOs) in mice
has failed to recapitulate pathology (Lagier-Tourenne et al.,
2013; Koppers et al., 2015; Atanasio et al., 2016; Jiang et al.,
2016; O’Rourke et al., 2016). C9orf72 knockdown in murine
models produces an altered immune response (Atanasio et al.,
2016) characterized by the accumulation of lysosomal vesicles
within macrophages, implicating a role for the C9orf72 protein
in the regulation of late endosomal/lysosomal trafficking in
macrophages and microglia (O’Rourke et al., 2016). The C9orf72
protein functions as a guanine exchange factor (GEF) for
Rab GTPases to regulate vesicular trafficking and autophagy
(Webster et al., 2016). Several independent reports have shown
that the C9orf72 long isoform forms a complex with WDR41 and
SMCR8 proteins, both regulators of autophagy (Blokhuis
et al., 2016; Sellier et al., 2016; Sullivan et al., 2016; Xiao et al.,
2016).
It is becoming increasingly apparent that altered RNA
processing plays a key role in C9orf72-mediated toxicity
through two separate, albeit related, aspects of RNA processing
(Figure 2). The first is altered processing of the expanded
C9orf72 transcript itself, in terms of altered transcription,
splicing defects, nuclear aggregation and non-conventional
translation. The second represents downstream and indirect
changes in RNA processing of other transcripts. Far from
being disparate entities in their role in C9orf72 toxicity,
we highlight how RNA and protein frequently interact and
drive disturbances in RNA metabolism. In this review article
we describe aspects of the pathomechanism of C9orf72-
associated ALS/FTD linked to disturbances at the RNA level
and how these changes may drive further RNA processing
abnormalities.
TDP-43 IS AN ESSENTIAL MEDIATOR OF
RNA METABOLISM
A characteristic pathological hallmark of ∼90% of ALS and
∼60% of FTD cases, including c9ALS/FTD cases is the
presence of cytoplasmic, ubiquitin-positive, inclusions of the
DNA/RNA binding protein, TDP-43, in affected neurons
(Neumann et al., 2006; Mackenzie et al., 2014). In disease,
TDP-43 aggregates in the cytoplasm where it undergoes a series
of post-translational modifications, including ubiquitination,
phosphorylation and C-terminal cleavage (Neumann et al.,
2006). TDP-43 is mainly a nuclear protein and its mislocalization
to the cytoplasm and aggregation are associated with a
reduction and subsequent loss of function. Mislocalization of
TDP-43 from the nucleus to the cytoplasm is likely to be
a key mediator of pathogenesis, as mutations in TARDBP,
the gene encoding TDP-43, are causative of some forms
of familial ALS (Kabashi et al., 2008; Sreedharan et al.,
2008).
TDP-43 is a highly conserved RNA-binding protein (RBP),
possessing two RNA recognition motif (RRM) domains. TDP-43
regulates splicing, RNA turnover and transport and therefore
interacts with a myriad of proteins involved in RNA metabolism
(Buratti and Baralle, 2010; Blokhuis et al., 2016). Downregulation
of TDP-43 expression in the CNS alters the expression of
∼600 transcripts and splicing of over 900 genes, the majority
of which are implicated in synaptic transmission, neuronal
development and RNA metabolism (Polymenidou et al., 2011;
Tollervey et al., 2011). Depletion of TDP-43 reduces the
expression of long intron-containing transcripts, the majority
of these essential for maintaining neuronal integrity (Lagier-
Tourenne et al., 2012). ALS-causing TDP-43 mutations can
also disrupt the splicing pattern of its mRNA targets in the
absence of TDP-43 mislocalization and aggregation, resulting
in abnormal splicing of transcripts involved in neurological
function (Arnold et al., 2013). One function of TDP-43 is
that it serves to repress splicing of nonconserved cryptic exons
(Ling et al., 2015). Cryptic exons are stretches of nucleotides
surrounded by sequences similar to authentic splice sites but
which are not normally recognized as such so are not spliced into
the wild-type RNA. Inclusion of a cryptic exon often results in
the introduction of a premature stop codon, resulting in either
protein truncation or mRNA degradation through nonsense-
mediated decay. Cryptic exon inclusion occurs in Alzheimer’s
brain exhibiting TDP-43 nuclear clearance in the absence of
inclusion formation, suggesting that cryptic exon inclusion
occurs as an early event among TDP-43 proteinopathies (Sun
et al., 2017).
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FIGURE 1 | C9orf72 RNA transcript variants. Schematic representation of the C9orf72 gene and RNA transcript variants. Exons are depicted as blue boxes and the
location of the GGGGCC repeat expansion is shown in purple. Differential selection of transcription start and termination sites generates three different RNA
transcripts. Variant 1 encodes a short protein isoform (isoform B) whereas variants 2 and 3 encode a longer protein isoform (isoform A). Presence of the repeat
expansion favors transcription from exon 1a, increasing the proportion of transcripts containing the repeat expansion.
TDP-43 not only serves to regulate coding RNAs but
is also implicated in the regulation of non-coding RNA
expression, including microRNA (miRNA) and long noncoding
RNA (lncRNA). TDP-43 associates with both microprocessor
complexes and its depletion results in reduced binding efficiency
of both complexes to a subset of miRNAs (Kawahara and
Mieda-Sato, 2012). In addition to facilitating miRNA biogenesis
on a global level, TDP-43 can directly bind miRNAs or their
precursors, including let-7b, miR-663 (Buratti et al., 2010)
and miR-9 (Zhang et al., 2013). TDP-43 depletion results in
downregulation of let-7b which in turn is associated with
altered expression levels of several let-7b targets. (Buratti et al.,
2010). Included in these targets are STX3 and VAMP3 which
are involved in synaptic vesicle formation and synaptic
exocytosis, respectively (Darios and Davletov, 2006; Deák et al.,
2006). Another transcript affected by let-7b downregulation is
DYRK1A, upregulation of which is associated with neuronal
deficits in individuals with Downs syndrome (Lepagnol-Bestel
et al., 2009).
LncRNAs make up an extensive family of long (several
kb) RNA molecules which serve key regulatory roles and
have been implicated in numerous cellular pathways. In cases
of sporadic frontotemporal lobar degeneration with TDP-43
pathology, TDP-43 exhibits significantly increased binding to
MALAT and NEAT1 lncRNAs (Tollervey et al., 2011). MALAT1
influences the phosphorylation patterns of the SR-family of
splicing proteins and recruits splicing factors to nuclear speckles
(Tripathi et al., 2010). NEAT1 is responsible for paraspeckle
assembly (Clemson et al., 2009), nuclear domains implicated
in transcriptional regulation, pre-mRNA splicing and mRNA
nuclear retention. Downregulation of TDP-43 results in a
corresponding decrease in MALAT1 expression (Guo et al.,
2015), suggesting that loss of TDP-43 nuclear function could
result in splicing abnormalities through altered expression of
MALAT1 lncRNA.
Furthermore, TDP-43 facilitates transport and local
translation of its mRNA targets within distal neuronal regions.
In Drosophila motor neurons, mouse cortical neurons and motor
neurons derived from human induced pluripotent stem cells
(iPSCs), TDP-43 associates with bidirectionally transported
messenger ribonucleoprotein complex (mRNP) granules. In
neuronal cells harboring ALS-causing TDP-43 mutations, the
anterograde transport of mRNP granules is selectively impaired
(Alami et al., 2014), suggesting that impaired axonal transport
of TDP-43 target mRNAs may contribute to ALS-associated
pathogenesis.
Due to the multitudinous roles of TDP-43 in the metabolism
of not only messenger RNAs, but also miRNAs and lncRNAs, it is
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FIGURE 2 | Summary of misregulated RNA processing events in c9ALS/FTD. RNA processing abnormalities in c9ALS/FTD brain tissue or in cellular and animal
models have been defined in almost every aspect of RNA processing, from DNA transcription to its translation and eventual degradation. Misregulated and/or
pathogenic processes involving the expanded C9orf72 transcript itself are depicted on the left hand side and labeled in purple, with the repeat expansion
represented as a yellow triangle. Such processes include bidirectional transcription of the repeat-containing allele, abortive transcription, decreased splicing of the
repeat-containing intron, sequestration of RNA binding proteins by RNA foci, repeat-associated non-AUG (RAN) translation and the incorporation of the expanded
transcript into RNA transport granules. Disrupted general RNA processing pathways are shown on the right and labeled in red, including decreased splicing
consistency, differential use of polyadenylation sites (PASs) and reductions in translation.
perhaps unsurprising that TDP-43 proteinopathies present with
disruptions in RNA at so many levels. Defective RNA processing
may represent a common pathway connecting FTD and ALS,
although the mechanism by which TDP-43 nuclear clearance
and aggregation results in such clinical heterogeneity remains
ambiguous.
RNA TOXICITY: THE ROLE OF
RNA-BINDING PROTEIN SEQUESTRATION
IN ALTERED RNA PROCESSING EVENTS
C9orf72 repeat RNA is bidirectionally transcribed, from both the
sense (G4C2)n and the antisense (G2C4)n DNA strand (Zu et al.,
2013), a phenomenon which appears to be more widespread
than previously recognized (Pelechano and Steinmetz, 2013).
Repeat RNA forms punctate nuclear aggregates termed RNA
foci. Multiple nuclear, and more rarely, cytoplasmic, sense
and antisense RNA foci have been identified in patient-
derived cells and throughout the CNS in expansion carriers
(Gendron et al., 2013; Lagier-Tourenne et al., 2013; Mizielinska
et al., 2013; Zu et al., 2013). Analyses of the distribution
and abundance of RNA foci initially revealed a significant
correlation with clinical phenotype (Cooper-Knock et al., 2014)
and an inverse correlation with age of onset (Mizielinska
et al., 2013), implicating RNA foci formation as a key driver
of C9orf72 toxicity. However, extensive characterization in
a larger cohort found no association between RNA foci
distribution and clinical phenotype. RNA foci load is highest
in cerebellar Purkinje cells, the loss of which has not
been described in C9orf72 expansion carriers. Interestingly,
a higher percentage of antisense foci in the frontal cortex
appear to correlate with a later age of onset, particularly
in patients diagnosed with FTLD (DeJesus-Hernandez et al.,
2017).
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BOX 1 | The mechanism of repeat-associated non-AUG (RAN) translation.
The type of repeat-containing RNA species that are exported to the cytoplasm
and subject to RAN translation is still to be elucidated. However several
recent results support the notion that the substrate for RAN translation of
G4C2 repeats into dipeptide repeat proteins (DPRs) is a mature mRNA. First
G4C2 repeats have been shown to cause overt neurotoxicity in Drosophila
only if there are in the context of an mRNA (Tran et al., 2015). Second,
initiation of RAN translation at CGG repeats, causing Fragile X tremor ataxia
syndrome (FXTAS), requires a 5′ 7-methylguanosine (m7G) cap (Kearse et al.,
2016). Addition of an m7G cap is part of the final processing of mRNA. In
patient tissues, the repeat-containing intron has been shown to be retained
in a proportion of polyadenylated C9orf72 RNA species in which downstream
exons were spliced correctly resulting in a C9orf72 mRNA with an enlarged
5′-untranslated region (5′-UTR) containing the G4C2 repeat domain (Niblock
et al., 2016). These species would be exported to the cytoplasm through
the conventional pathway of mRNA export and have a 5′ m7G cap and are
therefore the prime candidates for the template for RAN translation of G4C2
repeats into DPRs.
Finally, the study of Kearse et al. (2016) revealed that the mechanism of
RAN translation may more closely resemble the canonical mode of translation
than previously thought. The canonical mode of translation initiation occurs
by recruitment of various initiation factors to the 5′ m7G cap, which scan
the mRNA in search of an AUG initiation codon. In the case of microsatellite
repeat disorders in which translation occurs in the absence of an AUG
codon, RAN translation may occur in a similar fashion to internal ribosomal
entry site (IRES)-mediated translation initiation (Chiang et al., 2001), in which
secondary structures directly recruit initiation factors. Indeed, previous studies
have identified a requirement for the formation of hairpin secondary structures
to initiate RAN translation, as repeat sequences unable to form such secondary
structures are not subject to RAN translation (Zu et al., 2011). However, RAN
translation of CGG repeats is dependent on the m7G cap and eIF4E and
eIF4A initiation factors, utilizing a scanning mechanism to initiate translation
at codons which slightly deviate from the AUG sequence, located upstream
of the repeats or within the repeat sequence itself. The secondary structure
formed by CGG repeats may stall the initiation complex as it scans the mRNA
transcript, resulting in the utilization of near-AUG sequences upstream of the
repeats as alternative initiation codons (Kearse et al., 2016).
Since the discovery of RNA foci in c9ALS/FTD patient
tissue, RNA toxicity has emerged as a leading hypothesis for
C9orf72-associated pathogenesis. The RNA toxicity hypothesis
postulates that G4C2 repeats accumulate into nuclear RNA
foci and sequester essential RBPs, impairing their ability to
regulate their RNA targets and culminating in a range of
RNA misprocessing events. RNA pull-down and colocalization
experiments in c9ALS brain and neurons derived from iPSCs
(iPSNs) have identified a panel of RBPs binding to G4C2
repeat RNA, including hnRNP A1, hnRNP A3, hnRNP H,
ADARB2, Pur-α, ASF/SF2, ALYREF and nucleolin (Donnelly
et al., 2013; Lee et al., 2013; Mori et al., 2013a; Sareen et al.,
2013; Xu et al., 2013; Cooper-Knock et al., 2014; Haeusler et al.,
2014). Sense and antisense RNA foci sequester a similar panel
of RBPs, specifically SC35, hnRNP K, hnRNP A1, ALYREF
and hnRNP H (Cooper-Knock et al., 2014). Interestingly, only
antisense foci demonstrate a significant positive correlation with
TDP-43 mislocalization in motor neurons of c9ALS patients
(Cooper-Knock et al., 2015b), which in turn is associated with
neurodegeneration (Davidson et al., 2016). ASOs targeting the
C9orf72 transcript downstream of the repeats reduce RNA
foci levels (Donnelly et al., 2013; Jiang et al., 2016), attenuate
sequestration of specific RBPs and normalize gene expression
changes (Donnelly et al., 2013), suggesting that transcriptome
alterations represent a direct downstream consequence of G4C2
RNA toxicity. Upregulation of C9orf72 mRNA expression is
associated with concomitant downregulation of genes enriched
for functions in RNA metabolism, such as genes encoding tRNA
synthetases (Nataf and Pays, 2015) emphasizing the role of
tRNA metabolism in motor neuron degeneration (Weitzer et al.,
2015). Such downregulation of genes involved in the regulation
of RNA metabolism is consistent with RBP sequestration by
the C9orf72 hexanucleotide repeat expansion, as the reduced
pool of RBPs is less able to promote the expression of such
transcripts.
DPR ACCUMULATION IS DETRIMENTAL
TO NUMEROUS CELLULAR PATHWAYS
Sense and antisense C9orf72 RNA repeats are translated by an
unconventional form of translation, repeat-associated non-AUG
initiated translation (RAN translation) (Box 1). RAN translation
was first described in the context of spinocerebellar ataxia
type 8 (SCA8) caused by a CTG repeat expansion. RAN
translation of (G4C2).(C4G2)n results in the synthesis of five
dipeptide repeat protein (DPR) species; poly-GA, poly-GP,
poly-GR, from the sense transcript and poly-GP, poly-PR and
poly-PA, from the antisense transcript. All five DPR species
form ubiquitinated inclusions in cerebellum, hippocampus and
other brain regions in expansion carriers (Ash et al., 2013;
Gendron et al., 2013; Mann et al., 2013). Several studies have
demonstrated the toxicity of DPRs in vitro and in vivo (Kwon
et al., 2014; Mizielinska et al., 2014; Wen et al., 2014; Zhang
et al., 2014). Poly-GA expression in primary neurons reduces
dendritic branching, increases apoptosis through caspase-3
activation (May et al., 2014) and induces ER stress (Zhang
et al., 2014). The arginine-rich DPRs, poly-GR and poly-PR,
exhibit the most robust toxicity in transgenic fly models
and motor neuron cultures (Mizielinska et al., 2014; Wen
et al., 2014). Expression of (PR)50 and (GR)50 dramatically
decreases survival of primary cortical and motor neurons,
presumably through a pathway of translational dysregulation
(Wen et al., 2014). Poly-PR and poly-GR irreversibly bind
nucleoli and can alter the splicing patterns of specific RNAs.
For instance, when applied to cultured human astrocytes
(PR)20 penetrates cells and causes exon-skipping in RAN
and PTX3 RNA, resulting in the production of mRNAs
encoding truncated proteins and in impaired biogenesis of
ribosomal RNA, suggestive of nucleolar dysfunction (Kwon
et al., 2014). A yeast genetic screen demonstrated that deletion
of specific genes involved in ribosomal RNA processing, such
as NOB1 and NSR1, suppressed poly-PR toxicity (Jovi cˇi´c
et al., 2015). Consistent with these findings, a separate
study identified nuclear inclusions of poly-PR and poly-GR
tightly bound to nucleolar proteins, resulting in enlargement
of the nucleus and induction of apoptosis (Wen et al.,
2014).
While analyses of DPR interactomes have revealed
preferential interactions between poly-GA and proteins involved
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in proteasomal degradation (May et al., 2014; Zhang et al.,
2016), the arginine-rich DPRs bind to numerous interactors
enriched in RBPs and components of membrane-less organelles
(Lee et al., 2016; Lin et al., 2016; Boeynaems et al., 2017). A
significant number of these proteins possess low complexity
sequence domains (LCDs) which mediate the assembly of
membrane-less organelles such as RNA granules, nucleoli,
spliceosomes and the nuclear pore complex (NPC). In order
for membrane-less organelles to form they must separate from
the liquid cytoplasm, which is achieved by concentrating the
organelle components and the formation of a network of
weak multi-valent interactions, a process known as liquid-
liquid phase separation (LLPS) (Hyman et al., 2014). hnRNPs
including FUS, hnRNP A1 and TIA1 undergo LLPS and
aid the formation of stress granules (SGs) (Murakami et al.,
2015; Patel et al., 2015; Lin et al., 2016). Arginine-rich
DPRs are able to interact with the LCD of these proteins,
disrupting LLPS and altering their biophysical properties
(Lee et al., 2016). Therefore, DPRs may contribute to
toxicity by upsetting the composition of membrane-less
organelles.
Although the precise role of DPR toxicity in C9orf72-
associated pathogenesis remains controversial, it is evident that
their accumulation has detrimental effects on nucleolar function
and RNA metabolism. Specific effects of DPR aggregation on
RNA processing are discussed in further detail in the following
sections.
ASSESSING THE RELATIVE
CONTRIBUTION OF RNA FOCI AND DPR
ACCUMULATION TO C9orf72 TOXICITY
Since the discovery of RNA foci and RAN translation products in
cells derived from expansion carriers, the relative contribution of
these disease parameters to the overall pathomechanism remains
a controversial issue. The main argument against the role of
DPRs as a main driver of toxicity comes from neuropathological
analysis using human brain tissue, which has revealed that DPR
distribution is not spatially correlated to severity of degeneration
in ALS or FTD (Mackenzie et al., 2013; Davidson et al., 2014,
2016; Gomez-Deza et al., 2015; Schuldi et al., 2015). In fact,
DPR load is lower in vulnerable regions (e.g., motor cortex)
and higher in unaffected areas (e.g., cerebellum) (Mackenzie
et al., 2013), suggestive of a possible neuroprotective role
for insoluble DPR aggregates. On the other hand, extensive
quantification of RNA foci in the frontal cortex and cerebellum of
C9orf72 expansion carriers revealed limited association between
clinic-pathological phenotypes (DeJesus-Hernandez et al., 2017),
suggesting that neither RAN translation nor RNA foci can
in isolation account for the phenotypic heterogeneity among
expansion carriers. Even together, their presence is insufficient
to cause disease, as evidenced by a patient with 30× repeats
exhibiting both RNA foci and DPRs in the absence of TDP-43
pathology or clinical symptoms (Gami et al., 2015). This
suggests that longer repeat lengths overcome a pathological
threshold, enabling these initial molecular abnormalities to
trigger full-blown disease.
In order to elucidate the relative contributions of RNA
toxicity and RAN translation, several experimental strategies
employing the use of randomized codon constructs and G4C2
repeats containing stop codon interruptions have been developed
to determine the effects of RNA or DPRs in isolation. The results
of these studies are summarized in Table 1. Taken together,
these studies suggest that G4C2 toxicity is mediated through
the expression of arginine-rich DPRs, particularly poly-PR,
which induce nucleolar stress. However, the fact that we cannot
conclusively prove that RNA or DPRs alone act as a main driver
of C9orf72 toxicity indicates that it is a combination of the two,
perhaps in parallel with other disease factors, which is ultimately
responsible for disease.
PROCESSING OF THE EXPANDED C9orf72
ALLELE TRANSCRIPT
Owing to the high guanine content of the sense transcript,
the G4C2 repeat expansion forms highly stable G-quadruplex
structures (Figure 3). G-quadruplexes consist of stacks of planar
tetramers in which four guanines interact through Hoogsteen
hydrogen bonds. Furthermore, the antisense transcript adopts
i-motif secondary structure, consisting of two parallel duplexes
held by hemi-protonated C+-C pairs, under near physiological
conditions (Kovanda et al., 2015). Highly sensitive gene
expression profiling identified increased levels of potentially
truncated transcripts compared to controls in the frontal cortex,
an effect most prominent among patients diagnosed with
FTD (van Blitterswijk et al., 2015). Furthermore, a substantial
increase in the number of sense and antisense transcripts
containing intron 1 (the location of expansion) has been reported
among C9orf72 expansion carriers relative to controls in both
cerebellum (Mori et al., 2013b; Niblock et al., 2016) and patient-
derived iPSNs (Sareen et al., 2013). This suggests that the
presence of the repeat expansion results in preferential use
of exon 1a, resulting in a transcriptional bias towards the
expanded transcript (Sareen et al., 2013). It is of interest to note
that levels of intron 1 containing transcripts are significantly
higher in the frontal cortex of FTD patients compared to
individuals with ALS (Mori et al., 2013b; van Blitterswijk et al.,
2015).
Analysis of C9orf72 intron 1 splicing demonstrated
that a proportion of polyadenylated C9orf72 transcripts
retained intron 1. Intron retention was significantly
increased in the frontal cortex from C9orf72 expansion
carriers compared to controls. This effect was especially
pronounced in a case homozygous for the C9orf72 repeat
expansion (Niblock et al., 2016). These findings could reflect
the aforementioned transcriptional bias towards exon 1a,
thereby increasing the total number of transcripts containing
the expanded sequence. Of note, a relationship has been
established between high intronic GC content and splicing
abnormalities (Wong et al., 2013). Furthermore, reduced
rates of transcription across the intron owing to complex
secondary structure may contribute to perturbed splicing of
intron 1.
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TABLE 1 | Assessing the relative contributions of RNA and dipeptide repeat protein (DPR) toxicity in C9orf72 model organisms.
Experimental strategy Effect in model system References
Compared “pure repeats” (produced RNA foci and DPRs) with
“RNA-only repeats” containing stop-codon interruptions (produced
only RNA foci) in Drosophila
Eye degeneration occurs only when pure repeats are expressed. Mizielinska et al. (2014)
Pure repeats have no effect.
“Protein-only” constructs employing alternative codons to generate
DPRs in Drosophila
Arginine-rich DPRs cause eye degeneration and lethality. Mizielinska et al. (2014)
Alternative codons to generate DPRs expressed in cortical and
motor neurons
PR50 expression decreased cortical neuron survival. Wen et al. (2014)
Both PR50 and GR50 toxic in motor neurons.
Constructs containing intronic GGGGCC repeats (which do not
initiate RAN translation) expressed in cortical, motor and primary
cortical neurons
Increased death of cortical and motor neurons expressing 42×
repeats compared to 21× repeats and controls.
Wen et al. (2014);
Zhang et al. (2014)
Synthetic GR20 and PR20 peptides produced using a peptide
synthesizer applied to U2OS cells and human astrocytes
PR20 and GR20 bind nucleoli and kill U2OS cells. Kwon et al. (2014)
Disrupt splicing and ribosomal RNA biogenesis in astrocytes.
GFP-GA50 construct consisting of G4C2 repeats with stop codon
interruptions expressed in primary neurons
GA50 expression stimulates caspase-3 activation, ER stress and
decreased proteasome activity
Zhang et al. (2014)
Alternative codons to express poly-GA, poly-GR and poly-GP in
Drosophila
GR50 causes eye degeneration and death. Freibaum et al. (2015)
GA and GP expression has no effect.
Alternative codons to express poly-GR, poly-PR, poly-GA, poly-GP
and poly-PA in Drosophila
GR50 and PR50 causes severe eye degeneration. Lee et al. (2016)
GA50, GP50 and PA50 has no effect.
G4C2 repeats flanked by C9orf72 intronic and exonic sequences
which form RNA foci but low levels of DPRs compared to
G4C2 repeats with a poly(A) tail producing high levels of RAN
translation expressed in Drosophila
Intronic construct causes modest toxicity whereas poly(A) construct
produces severe eye degeneration.
Tran et al. (2015)
Alternative codons to express poly-GR, poly-PR, poly-GA, poly-GP
and poly-PA in S. cerevisiae
PR50 expression is sufficient to disrupt nuclear pore trafficking Jovicˇi´c et al. (2015)
Taken together, these results suggest that the presence of
the expanded G4C2 sequence and the formation of complex
secondary structure results in numerous transcriptional defects,
including abortive transcription, increased use of exon 1a and
ineffective splicing of the repeat-containing intron.
FIGURE 3 | C9orf72 transcript secondary structures. Highly stable
G-quadruplex secondary structures form on the expanded (GGGGCC)n
transcript, increasing the likelihood of R-loop formation.
GLOBAL SPLICING ALTERATION
C9orf72 RNA foci sequester several members of the hnRNP
family of splicing factors (Lee et al., 2013; Mori et al., 2013a;
Sareen et al., 2013; Cooper-Knock et al., 2014), resulting in
altered splicing patterns of their RNA targets. The production
of certain alternatively spliced mRNAs depends on the
relative abundance of antagonistically acting splicing factors,
highlighting the potential implications of hnRNP sequestration
within G4C2 foci. Multiple lines of evidence point towards
perturbations in constitutive and alternative splicing events
in C9orf72 expansion carriers. Gene expression profiling has
revealed an increased occurrence of splicing errors in cell
lines derived from c9ALS patients, an effect which was most
evident among patients with faster disease progression (Cooper-
Knock et al., 2015a). Transcriptome analysis of differentially
expressed genes between c9ALS and control groups revealed an
enrichment of upregulated transcripts involved in RNA splicing
(Cooper-Knock et al., 2015a), consistent with a compensatory
mechanism for RBP sequestration by RNA foci. Many of the
differentially expressed genes have also been independently
identified as candidate G4C2 binding proteins, including hnRNP
A3 and hnRNP H (Lee et al., 2013; Mori et al., 2013a).
These results suggest that the increased splicing error rate
in expansion carriers is a consequence of RBP sequestration
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into foci, which in turn contributes to disease progression
and severity. Consistent with this hypothesis, analysis of
abundant RBP motifs among transcripts exhibiting splicing
abnormalities revealed an enrichment for binding motifs for
hnRNP H (Prudencio et al., 2015). Furthermore, an additional
transcriptome analysis reported a three-fold increase in the
number of splicing events in c9ALS cases compared to sporadic
ALS in both cerebellum and frontal cortex (Prudencio et al.,
2015). Intron retention events embodied a significant proportion
of such splicing events, revealing a staggering 40-fold increase
among c9ALS compared to sporadic ALS within the frontal
cortex. Such differences in the extent of intron retention in
c9ALS may contribute to the reported increase in nuclear
accumulation of mRNA transcripts in C9orf72-ALS models
(Freibaum et al., 2015; Jovi cˇi´c et al., 2015; Rossi et al.,
2015).
Splicing abnormalities also arise from pathogenic events
other than RBP sequestration into foci, such as DPR toxicity.
Exposure of cultured cells to arginine-rich DPRs results in
their localization to the nucleus where they bind nucleoli,
resulting in disruptions in ribosomal RNA biogenesis (Kwon
et al., 2014). Furthermore, PR20 exposure produced altered
splicing patterns of specific mRNA transcripts, including exon
skipping and intron retention events. PR20 expression caused
exon 2 skipping of the mRNA encoding Ran GTPase, producing
a protein of reduced length. Ran GTPase functions as a
regulator of protein nucleocytoplasmic transport, which has
been implicated in C9orf72-mediated toxicity and is discussed
in further detail below. Exposure to PR20 also promotes
intron retention within the GADD45 mRNA, altering the open
reading frame and thereby encoding an inactive version of the
GADD45 protein (Kwon et al., 2014). Such findings suggest
a possible contribution of DPR proteins to the alternative
splicing abnormalities documented in c9ALS. Indeed, impaired
ribosomal RNA biogenesis and RNA granule formation due
to DPR expression suggest that DPRs may perturb RNA
processing on a global level (Kwon et al., 2014; Tao et al.,
2015).
Thus, TDP-43 loss-of-function, RBP sequestration and the
production of DPR species converge to disrupt splicing patterns
of mRNAs in various cellular pathways. Perturbations in
numerous signaling pathways may explain why so many
processes, from autophagy to the stress response, are impaired
in C9orf72-disease.
GLOBAL CHANGES IN
POLYADENYLATION SITE SELECTION
In addition to alterations in alternative splicing, variations
in polyadenylation site (PAS) selection of a large number of
transcripts have been identified in the cerebellum of individuals
with C9orf72-ALS. Analogous to alternative splicing, alternative
PAS selection contributes to the complexity of the human
transcriptome and has been detected in over 50% of human
genes (Tian et al., 2005). Alternative polyadenylation generates
mRNA isoforms which vary in their 3′-untranslated regions
(3′-UTRs), thus determining the stability, localization and
translational efficiency. c9ALS patients show increased use
of upstream PASs compared to downstream PASs in the
cerebellum compared to sporadic ALS patients (Prudencio
et al., 2015). Transcripts exhibiting shifts in PAS selection are
enriched for functions in RNA processing, including transcripts
encoding exosomal proteins, components of the RISC complex
and splicing factors, such as TARBP2, ATXN2 and EXOSC7
(Prudencio et al., 2015). 3′-UTRs frequently harbor miRNA
and RBP binding sites, therefore the selection of upstream
PASs, which reduce the length of the 3′-UTR, are likely to
result in the loss of such binding sites. mRNA transcripts
with shorter 3′-UTRs have an increased stability, resulting in
higher protein expression and thereby generating distortions in
downstream pathways (Matoulkova et al., 2012). Altered 3′-UTR
length may also affect the stability, localization and transport
of the mRNA. In addition to its role in alternative splicing,
hnRNP H has also been implicated in alternative PAS selection
(Chou et al., 1999), suggesting a role for RBP sequestration
in disrupted alternative polyadenylation events in C9orf72-
mediated toxicity.
NUCLEOCYTOPLASMIC TRANSPORT
Mature mRNA transcripts are transported to the cytoplasm from
the nucleus through large proteinaceous assemblies embedded
in the nuclear envelope, termed NPCs. The mRNA transcript,
together with proteins involved in pre-mRNA processing, exist
as a large mRNP which interacts with the NPC through
nuclear transport receptors. RNA processing reactions generate
signals in the form of proteins docked onto the mature mRNA
which interact with the nuclear export machinery, ensuring that
only fully matured mRNAs are transported to the cytoplasm
for translation (Brodsky and Silver, 2000). For example, the
UAP56 helicase is retained onto the mRNA after splicing and
recruits the nuclear export protein, ALYREF, thereby coupling
splicing to nuclear export (Luo et al., 2001). Conversely,
following translation, nuclear proteins are transported from the
cytoplasm to the nucleus. The vast majority of nuclear proteins
are transported from the cytoplasm via the Ran-mediated
pathway, which is an energy-dependent directional process
reliant on the asymmetric distribution of Ran-GTP in the
nucleus and Ran-GDP in the cytoplasm. RanGAP functions
as a molecular switch, converting Ran-GTP to Ran-GDP,
enabling Ran to shuttle proteins into the cytoplasm and
maintaining the gradient of cytoplasmic Ran-GDP (Figure 4).
Ran-mediated nucleocytoplasmic trafficking is facilitated by
the karyopherin protein family (consisting of importins and
exportins which mediate nuclear import and export, respectively)
which form a complex with Ran, cargo proteins and components
of the NPC.
A genetic screen in Drosophila expressing (G4C2)30 repeats
identified RanGAP as a potent suppressor of the rough eye
phenotype (Zhang et al., 2015), suggesting that upregulation of
protein nuclear import can alleviate C9orf72-associated toxicity.
Furthermore, RanGAP was shown to physically interact with
G4C2 RNA repeats and exhibited mislocalization from the
nuclear periphery into large perinuclear aggregates in Drosophila
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FIGURE 4 | Ran-mediated protein nuclear import. The import of proteins into the nucleus is dependent on a concentration gradient of Ran-GDP:Ran-GTP in the
cytoplasmic and nuclear compartments, respectively. RanGAP converts Ran to its GDP-bound form, enabling Ran to shuttle proteins possessing a nuclear
localization signal (NLS) into the nucleus. Nuclear import of TDP-43 depends on the Ran-mediated pathway; therefore RanGAP mislocalization could contribute to
TDP-43 nuclear depletion.
expressing (G4C2)30, in patient-derived iPSNs and in the motor
cortex from c9ALS patients. A significant correlation between
the nuclear to cytoplasmic ratios of Ran and TDP-43 has been
established (Ward et al., 2014; Zhang et al., 2015), implying a
role for Ran in the nuclear import of TDP-43. Indeed, siRNA
knockdown of Ran accessory proteins, such as importin-β1,
which function in the nuclear import of proteins with a nuclear
localization signal (NLS), results in the cytoplasmic accumulation
of TDP-43 (Nishimura et al., 2010). Furthermore, TDP-43
regulates Ran expression through interaction with the 3′-UTR of
Ran mRNA and TDP-43 inhibition leads to a decrease in Ran
mRNA and protein expression (Sephton et al., 2011; Ward et al.,
2014).
Xiao et al. (2015) reported a direct interaction between
the C9orf72 protein with Ran and importin-β1, implicating
a potential role for the C9orf72 protein in nucleocytoplasmic
trafficking. This group demonstrated redistribution of the
C9orf72 short isoform (isoform B) from the nuclear membrane
in healthy neurons to the plasma membrane in neurons
from c9ALS patients. Loss of C9orf72 isoform B, Ran and
importin-β1 from the nuclear membrane correlated with TDP-43
mislocalization and aggregation (Xiao et al., 2015).
Another genetic screen in Drosophila expressing (G4C2)58
specifically identified disruptions in the protein and mRNA
nuclear export pathways (Freibaum et al., 2015). (G4C2)58
toxicity is exacerbated by disruptions to the CRM1-mediated
nuclear export pathway, the pathway responsible for the nuclear
export for the majority of proteins and RNA transcripts.
Depletion of the nuclear pore components Nup107 or
Nup160 which function in RNA nuclear export exacerbates
degeneration caused by (G4C2)58. Furthermore, downregulation
of Ref1, the Drosophila ortholog of ALYREF, was identified
as the strongest suppressor of toxicity (Freibaum et al., 2015).
Immunohistochemistry and UV crosslinking have previously
demonstrated colocalization to foci and direct binding of
ALYREF with both sense and antisense RNA in c9ALS motor
neurons (Cooper-Knock et al., 2014, 2015b). Through its
interaction with the TREX complex, ALYREF protects the
mRNP from exosomal degradation (Chang et al., 2013),
therefore the suppressive effect of Ref1 loss of function results
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 July 2017 | Volume 11 | Article 195
Barker et al. RNA Misprocessing in C9orf72-Linked Neurodegeneration
from increased exosomal degradation of nuclear transcripts. A
higher proportion of nuclear to cytoplasmic mRNA transcripts
were identified in G4C2-expressing Drosophila and c9ALS
iPSNs, an effect rescued by Ref1 knockdown. Moreover, loss
of exosomal function was demonstrated to enhance toxicity
(Freibaum et al., 2015) and mutations in EXOSC3 which encodes
an exosomal component are responsible for a congenital form of
motor neuron disease, pontocerebellar hypoplasia (Wan et al.,
2012).
To elucidate the contribution of RNA and DPR toxicity
to nucleocytoplasmic defects, a yeast genetic screen was used
to generate poly-PR employing codon-optimized constructs
without using the G4C2 repetitive sequence. The strongest
suppressors of toxicity were identified as members of the
karyopherin family of nuclear import proteins and MTR10,
a nuclear import receptor which mediates the import of the
serine-arginine (SR) family of splicing factors (Jovi cˇi´c et al.,
2015). It has been previously suggested that DPRs may compete
with SR proteins for binding to ribonucleoproteins, as both
the SR-domains of splicing factors and synthetic constructs
containing 20 GR or PR repeats both bind hnRNP A2 hydrogels
(Kwon et al., 2014). Upregulation of MTR10 could alleviate this
competitive effect, thereby increasing the influx of SR proteins
into the nucleus. This would restore alterations in RNA splicing
and processes, such as mRNA nuclear export and nonsense-
mediated decay. Consistent with the Drosophila genetic screens,
the same group also identified components of the NPC and
Ran-associated proteins as genetic modifiers of (PR)50 toxicity in
yeast.
Taken together, the results of these studies suggest that
abnormal nucleocytoplasmic transport is a pathological
signature of c9ALS/FTD. Disruptions in nucleocytoplasmic
transport have also been documented in a mutant SOD1 mouse
model of ALS (Zhang et al., 2006), suggestive of an underlying
defect common to ALS with different genetic etiologies. Nuclear
import and export factors therefore represent a potential
therapeutic target for G4C2 repeat toxicity. ASOs targeting
the C9orf72 transcript have already been shown to normalize
Ran and TDP-43 localization in neurons derived from c9ALS
iPSCs, presumably through the reduction of G4C2 RNA foci
(Zhang et al., 2015). In addition, small molecules which
disrupt the G-quadruplex conformation of G4C2 RNA rescue
nuclear import deficits in the (G4C2)30 Drosophila model
(Zhang et al., 2015), highlighting the therapeutic amenability of
nucleocytoplasmic transport.
mRNA LOCALIZATION AND TRANSLATION
Expanded G4C2 RNA localizes to neurites where it is
subsequently incorporated into active transport granules
in Drosophila neurons and iPSNs from expansion carriers
(Burguete et al., 2015). RNA transport granules are
ribonucleoprotein complexes which serve to transport
mRNA along microtubules for local protein synthesis. For
highly polarized cells, such as neurons, efficient mRNA
transport and local translation is crucial for the maintenance
of synaptic plasticity. Localization of the G4C2 repeat RNA
to neuronal transport granules is associated with neuritic
branching deficits which are modulated by the components
of transport granules and translational regulators, FMRP
and CPEB3 (Burguete et al., 2015), suggesting that loss of
neuritic branches may result from transport of G4C2 repeat
RNA in neurites. Secondary structural conformations, such
as G-quadruplexes, appear to promote neuritic localization
of G4C2 repeat RNA and incorporation into RNA transport
particles (Subramanian et al., 2011; Burguete et al., 2015),
therefore targeting specific structural conformations may
promote neuritic branching of neurons in repeat expansion
carriers. Of note, binding partners and modifiers of G4C2
repeat toxicity, including hnRNP A3, hnRNP A2/B1 and
Pur-α, are responsible for maintaining transport granule
function (Jin et al., 2007; Sofola et al., 2007; Xu et al.,
2013).
Impairment in the mRNA nuclear export pathway is
predicted to result in reduced translation of mRNA into
proteins. Indeed, downregulation of protein translation has been
documented in cells expressing (G4C2)31. An RNA pulldown
assay using (G4C2)31 revealed binding proteins enriched for
functions in translational control, such as EF1α, eIF2α, eIF2β
and Pur-α, indicating that protein sequestration by the repeat
expansion may also contribute to impaired translation (Rossi
et al., 2015). Expression of the G4C2 sequence in cultured
mammalian cells initiates a stress response, characterized by the
formation of SGs and a subsequent reduction in the rate of global
translation (Rossi et al., 2015). SGs serve to protect the cell during
stress, transiently storing mRNAs encoding housekeeping genes
and prioritizing the translation of stress-response proteins, such
as heat shock proteins and chaperones. SGs are composed of
RBPs and poly(A)+ mRNAs, which are either transiently stored
to resume translation upon alleviation of the stress response
or are degraded in processing bodies (P-bodies; Bentmann
et al., 2013). Persistent SG formation results in a chronic stress
response and prolonged translational repression. Increasing
lines of evidence suggest that SG-associated translational
repression may play a role in c9ALS/FTD. For example,
TDP-43, FUS and Ataxin-2, mutations in which are associated
with neurodegenerative disease, all localize to SGs upon
cellular stress and may function to regulate SG assembly
(Wolozin, 2012; Monahan et al., 2016). Furthermore, genes
involved in SG formation are potent modifiers of TDP-43
toxicity in yeast and Drosophila (Kim et al., 2014). TDP-43
expression promotes eIF2α phosphorylation, indicative of SG
formation and translational repression. Inhibiting SG formation
using a small molecule inhibitor of eIF2α alleviates TDP-43
toxicity (Kim et al., 2014). eIF2α is crucial for translation
initiation, facilitating the interaction between the ribosome and
Met-tRNA. Phosphorylation of eIF2α results in its inactivation,
inhibiting global protein synthesis. SG formation can be
stimulated by limited availability of eIF2α (Mokas et al.,
2009), therefore eIF2α sequestration into RNA foci (Rossi
et al., 2015) has the potential to initiate SG formation and
translational inhibition. Arginine-rich DPR species impede
protein translation in a dose-dependent manner through a
mechanism independent of eIF2α phosphorylation (Kanekura
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et al., 2016). Immunoprecipitation analysis revealed that
poly-(PR)20 interacts with ribosomal proteins and translation
initiation and elongation factors. Furthermore, both poly-(PR)20
and poly-(GR)20 were shown to aggregate in the presence of
mRNA transcripts, obstructing access of the eIF4E and eIF4G
translation initiation factors and disrupting proteins translation
(Kanekura et al., 2016).
Consistent with reduced nuclear export, nuclear
accumulation of poly(A)+ mRNA transcripts was detected
in (G4C2)31-expressing cells and was strongly associated
with relocalization of cytoplasmic poly(A)-binding protein
(PABPc) to the nucleus. PABPc directly binds G4C2 RNA
and accumulates into RNA foci (Rossi et al., 2015). Of note,
targeting PABPc to the nucleus is sufficient to cause nuclear
accumulation of mRNAs (Kumar and Glaunsinger, 2010),
therefore nuclear sequestration of PABPc by G4C2 foci may
represent a potential link between RNA toxicity and nuclear
retention of mRNAs. Furthermore, PABPc plays a key role
in regulating mRNA translation by facilitating the interaction
between translation initiation factors and the mRNA 5′ cap,
enhancing ribosomal recruitment. PABPc nuclear sequestration
may reduce global translational efficiency of the depleted pool
of mRNAs present in the cytoplasm. Thus, sequestration of
translational regulators by RNA foci may result in the nuclear
retention of mRNAs and a concomitant reduction of translation
in the cytoplasm.
IMPAIRED RNA PROCESSING IS
ASSOCIATED WITH R-LOOP FORMATION
The occurrence of the G-quadruplex or i-motif structures
from the sense or antisense transcript, respectively, displaces
the complementary DNA strand, favoring the formation of
R-loop secondary structures. R-loops form during transcription
when the nascent RNA molecule interacts with displaced
DNA, resulting in the formation of a three stranded nucleic
acid structure consisting of an RNA:DNA hybrid and single
stranded DNA (ssDNA) (Figure 3), taking advantage of
the increased thermodynamic stability of RNA:DNA hybrids
compared to the DNA duplex. Conversely, perturbations in
RNA processing can result in increased formation of R-loop
structure (Huertas and Aguilera, 2003; Wahba et al., 2011).
R-loops may reduce transcriptional efficiency resulting in the
formation of aborted transcripts. An in vitro transcription
assay using G4C2 repeats that form G-quadruplex structures
demonstrated a repeat-length dependent accumulation of
transcripts truncated within the repeat expansion region. RNase
H treatment, which specifically digests the RNA transcript
within DNA-RNA duplexes and resolves R-loop structures,
reduces abortive transcripts (Haeusler et al., 2014). Of note,
mutations in senataxin, an RNA helicase which resolves R-loop
structures, are causative of ALS4, a juvenile form of ALS
(Chen et al., 2004). Depletion of the splicing factor ASF/SF2,
a protein shown to bind G4C2 repeat sequences (Reddy et al.,
2013; Rossi et al., 2015), results in a concomitant increase in
R-loop formation (Li and Manley, 2005). Furthermore, R-loops
are a known source of DNA damage (Huertas and Aguilera,
2003) and are likely to contribute to the upregulation of DNA
damage markers identified in ALS motor neurons (Farg et al.,
2017).
In addition to C9orf72-linked disease R-loop formation has
been characterized in several microsatellite disorders, such as
Fragile X Syndrome (FXS) and Friedrich’s Ataxia (FRDA) (Groh
et al., 2014). R-loops were found to be enriched over GAA repeats
associated with FRDA and the abundance of R-loops correlated
with repeat expansion length. Furthermore, increased formation
of R-loops resulted in upregulation of repressive chromatin,
promoting transcriptional silencing of the FXN gene (Groh et al.,
2014). Therefore, R-loop formation may contribute to some
of the processes characteristic of repeat expansion disorders,
including repeat instability, antisense transcription and impaired
transcription. Incubation of transcriptionally induced R-loops
with cell lysates stimulated variations in repeat length within
the DNA template (Reddy et al., 2014), suggesting that R-loop
formation can have direct consequences on repeat instability.
It remains unclear how R-loops promote repeat instability,
however it has been proposed that R-loop structures favor a non-
B-DNA structure of the ssDNA, resulting in the recruitment
of various DNA repair factors which mediate error-prone
DNA repair synthesis (Lin et al., 2010). R-loops also have the
ability to induce transcriptional pausing or stalling, perhaps
by forming a structural block or by triggering mechanisms of
transcriptional repression, such as histone methylation (Groh
et al., 2014; Skourti-Stathaki et al., 2014). Additionally, R-loops
may induce expression of the antisense transcript (Skourti-
Stathaki et al., 2014). The fact that R-loop formation is associated
with so many features of C9orf72 toxicity makes it an imperative
area of future research and a potential attractive therapeutic
target applicable to a range of microsatellite repeat disorders.
Small molecules able to intercalate within G-quadruplex or
hairpin structures have demonstrated promising suppression
of R-loops arising from trinucleotide expansions (Colak et al.,
2014).
CONCLUDING REMARKS
It is becoming clear that impaired RNA processing is a
central feature of c9ALS/FTD pathogenesis which is mediated
via several interconnected mechanisms, including sequestration
of RBPs, RAN translation and TDP-43 mislocalization. It is
likely that these mechanisms all contribute to RNA processing
abnormalities to different extents, generating numerous small
defects at the level of RNA metabolism. Initially the cell may be
able to compensate for these defects, however over time these
abnormalities may accumulate beyond a certain threshold at
which point the aging cell loses viability. The idea of c9ALS/FTD
as a disorder mediated by an accumulation of several minor
disruptions, rather than a few isolated RNA misprocessing events
as has been described for myotonic dystrophy type 1 (Timchenko
et al., 2001; Jiang et al., 2004), may in part account for the extreme
variability in clinical phenotypes exhibited by C9orf72 expansion
carriers. Given the importance of RNA processing in cellular
function, RNA metabolism can be considered an essential target
for therapeutic intervention to improve the lives of those living
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not only with c9ALS/FTD but for a range of neurodegenerative
disorders.
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